Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinoma

CONCLUSIONS: Gem/Doce demonstrates promising safety and efficacy as a renal-sparing treatment option for high-grade UTUC in appropriately selected patients.PMID:37805338 | DOI:10.1016/j.urolonc.2023.08.013

Source: Urologic Oncology - October 7, 2023 Category: Urology & Nephrology Authors: Ian M McElree Alex Belzer Sarah L Mott Vignesh T Packiam Michael A O'Donnell Ryan L Steinberg Source Type: research